Table 3.

Coexpression of CD Antigens on 97A6+Cells

PB CD34PB CD34+BM CD34BM CD34+PB CML d3 PB (+IL-3) d14 PB (+IL-3)
CD10  − nd  −  −  −  nd  −  
CD13 +  −  ±  ±  ±  −  ±  
CD16  − nd  nd  nd  ±  nd  −  
CD17  +  − ±  ±  ±  ±  −  
CD26  +  −  ±  +  ±  ±  
CD33  ±  +  +  +  +  +  
CD38  +  +  +  +  +  +  ± 
CD44  +  +  +  +  +  +  ±  
CD55  +  +  +  +  +  +  
CD59  +  +  +  +  +  +  
CD71  −  +  ±  +  −  ±  
CD81  ±  nd  +  +  +  +  +  
CD117 −  +  −  +  −  +  nd  
CD123  +  +  +  +  ±  nd  
CD164  +  +  +  +  −  ±  
IgE  +  ±  +  +  −  − ±  
HLA-DR  −  ±  ±  +  −  ± 
PB CD34PB CD34+BM CD34BM CD34+PB CML d3 PB (+IL-3) d14 PB (+IL-3)
CD10  − nd  −  −  −  nd  −  
CD13 +  −  ±  ±  ±  −  ±  
CD16  − nd  nd  nd  ±  nd  −  
CD17  +  − ±  ±  ±  ±  −  
CD26  +  −  ±  +  ±  ±  
CD33  ±  +  +  +  +  +  
CD38  +  +  +  +  +  +  ± 
CD44  +  +  +  +  +  +  ±  
CD55  +  +  +  +  +  +  
CD59  +  +  +  +  +  +  
CD71  −  +  ±  +  −  ±  
CD81  ±  nd  +  +  +  +  +  
CD117 −  +  −  +  −  +  nd  
CD123  +  +  +  +  ±  nd  
CD164  +  +  +  +  −  ±  
IgE  +  ±  +  +  −  − ±  
HLA-DR  −  ±  ±  +  −  ± 

BM and PB cells were labeled with anti-CD34-PerCP, 97A6-PE, and FITC-conjugated antibodies of the indicated specificities and analyzed on a FACSCalibur flow cytometer. CD34 and CD34+ cells were evaluated after gating on the respective populations using the Cellquest software. CML PB cells and CD34+ PB cells stimulated with 100 ng/mL IL-3 and harvested at days 3 and 14, respectively, were stained with 97A6-PE and FITC-conjugated antibodies of the indicated specificities. ± indicates positive subpopulation.

Abbreviation: nd, not determined.

or Create an Account

Close Modal
Close Modal